Skip to content
Governance Register

← US public companies

Fortress Biotech, Inc.

SEC CIK 1429260 · [CNDO] · last insider filing 2026-06-24

Directors (from insider filings)

NameCapacity as filedFilings
Weiss Michael S Director · See Remarks filed 2013 - 2026
Rosenwald Lindsay A MD Director · President, CEO & Chairman filed 2011 - 2026
Lobell J JAY Director filed 2011 - 2026
Hoenlein Malcolm Director filed 2014 - 2026
Harvey Jimmie Director filed 2011 - 2026
Klein Dov Director filed 2015 - 2026
Lorenz Kevin Director filed 2019 - 2026
Lu Lucy Director · Executive VP and CFO filed 2012 - 2025
Rowinsky Eric K Director · Vice Chairman of the Board filed 2011 - 2024
Barrett David Jonathan Director filed 2011 - 2014
Weisman Harlan F Director · Chairman and CEO filed 2012 - 2013
Sandage Bobby W. JR., PHD. Director · President and CEO filed 2011 - 2013
Rogers Michael W Director filed 2011 - 2013
Cooper Glenn L MD Director · See Remarks filed 2011 - 2012

Officers (from insider filings)

NameTitle as filedFilings
Jin David Chief Financial Officer filed 2022 - 2026
Hunter Robyn Chief Financial Officer filed 2017 - 2022
Avgerinos George SVP, Biologics Operations filed 2013 - 2019
Horgan Kevin Chief Medical Officer filed 2013 - 2014
Ritter Dale See General Remarks filed 2011 - 2013
Beerman Noah D See Remarks filed 2011 - 2013
Hehenberger Karin M. See Remarks filed 2012 - 2012

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.